Welcure Drugs & Pharmaceuticals Fair Value
Welcure Drugs & Pharmaceuticals (WELCURE) average fair value is ₹24.54 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹0.32 (+7570.0%), fair value range ₹9.2–₹45.83. For live price and a broader fundamental view, visit WELCURE share price.
Fair Value Analysis Export
WELCURE Fair Value vs Current Price — Valuation Summary
WELCURE average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Explore WELCURE Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
WELCURE Fair Value Analysis — Data Sources & Coverage
Welcure Drugs & Pharmaceuticals financial data sources, valuation methods applied and sector benchmarks used. Analyse WELCURE institutional holdings to track promoter, FII and institutional holdings.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
WELCURE vs Healthcare Sector Peers — P/E, P/B & Market Cap
Welcure Drugs & Pharmaceuticals P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Par Drugs & Chemical | PAR | - | 1.21 | ₹132 |
| Sat Kartar Shopping | SATKARTAR | 29.05 | 5.53 | ₹307 |
| Sanofi Consumer Healthca… | SANOFICONR | 43.83 | 27.4 | ₹10,638 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Acutaas Chemicals | ACUTAAS | 67.94 | 13.69 | ₹19,597 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.